Drug company start-up names management team
Iroko Pharmaceuticals L.L.C., Philadelphia, which last month acquired two Merck & Co. Inc. drugs, today named its management team - largely executives from big pharmaceutical companies.
Iroko Pharmaceuticals L.L.C., Philadelphia, which last month acquired two Merck & Co. Inc. drugs, today named its management team - largely executives from big pharmaceutical companies.
The president and chief executive is John Vavricka, 44, a former GlaxoSmithKline executive who most recently set up a Philadelphia office for Chiron Corp.'s vaccine business.
There are four other management team members, all of whom have worked in the Philadelphia area:
Chief financial officer Fred C. Krieger is a former vice president of financial planning at GlaxoSmithKline.
Executive director of manufacturing Joseph C. Crea had worked at Johnson & Johnson for 19 years.
Director of regulatory affairs Hanna Zyruk is a former manager of global labeling at Wyeth.
Vice president of corporate development Rohit C. Mehta had been a consultant to venture firms and global pharmaceutical and biotechnology companies.
